Sorrento Therapeutics, Inc.
(NASDAQ : SRNE)

( )
SRNE After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
-1.67%292.231.4%$590.52m
AMGNAmgen, Inc.
0.07%234.011.3%$503.19m
GILDGilead Sciences, Inc.
1.04%67.781.0%$366.31m
REGNRegeneron Pharmaceuticals, Inc.
1.59%373.532.6%$302.52m
VRTXVertex Pharmaceuticals, Inc.
-0.12%220.001.9%$273.01m
ILMNIllumina, Inc.
-1.95%320.573.5%$231.88m
ARWRArrowhead Pharmaceuticals, Inc.
-3.73%68.2211.4%$207.81m
CLVSClovis Oncology, Inc.
-3.14%11.7214.7%$207.81m
ALXNAlexion Pharmaceuticals, Inc.
-1.53%109.502.0%$195.03m
EXASEXACT Sciences Corp.
-0.15%85.1724.0%$163.33m
AAgilent Technologies, Inc.
0.60%83.431.6%$159.09m
GBTGlobal Blood Therapeutics, Inc.
3.29%78.456.0%$142.09m
BLUEbluebird bio, Inc.
1.49%86.9714.2%$139.80m
BOLDAudentes Therapeutics, Inc.
-0.12%59.441.4%$134.26m
SGENSeattle Genetics, Inc.
-2.32%111.346.1%$128.54m

Company Profile

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.